Skip to content

Omeros OMER Net Income

Net Income at other companies

Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-$49.66M-2.4%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-$44.9M+11.7%
Immunome logo
ImmunomeIMNM
-$53.84M-29.3%
Vor Biopharma logo
Vor BiopharmaVOR
-$219.59M-576%
Annexon logo
AnnexonANNX
-$44.14M+18.8%
Arcus Biosciences logo
Arcus BiosciencesRCUS
-$128M-14.3%

Other financials

Income statement

See full
Revenue$9.9M
Gross profit$29.7M
Operating income-$40.9M-9.2%
Net income$56.1M+268%
EPS (diluted)-$0.59-20.4%

Balance sheet

See full
Cash & equivalents$1.9M-55.3%
Total debt$13.5M-30.3%
Total equity-$63.3M+70.3%
Total assets$286.2M+21.7%

Cash flow

See full
Operating cash flow-$14.5M+59.5%
CapEx--100%
Free cash flow-$14.5M+59.6%

Valuation

See full
Market cap$765.73M+307%
P/S8.5×

Profitability

See full
Gross margin98.9%
Operating margin-181.8%
Net margin-136.6%
FCF margin-121.6%

Returns & leverage

See full
Return on equity86.6%
Debt / equity0.3×-1.1×
Current ratio+1.9×

Where this comes from

Reported directly by Omeros in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Omeros’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omeros's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omeros's net income?
Omeros (OMER) reported net income of $56.06M in Q1 2026.
How has Omeros's net income changed year-over-year?
Omeros's net income increased by 267.5% year-over-year, from -$33.46M to $56.06M.
What is the long-term trend for Omeros's net income?
Over 3 years (2021 to 2024), Omeros's net income has grown at a -6.9% compound annual growth rate (CAGR), from $194.24M to -$156.82M.
What does net income mean?
Net income as the starting point for the indirect method operating cash flow reconciliation.